Lineage Cell Therapeutics, Inc. (LCTX)

NYSE · Biological Products, (No Diagnostic Substances) · Inc. CA

What they're doing

Not enough recent activity to summarise.

Signals, last 12 months

No signals recorded in the last 12 months.

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-03-12Culley Brian MdirectorP15,0001.63$24,450
2026-02-11Culley Brian MdirectorM31,250
2026-02-11Culley Brian MdirectorF12,8691.8$23,164
2026-02-11Samuel George A. IIIofficerM6,075
2026-02-11Samuel George A. IIIofficerF2,5021.8$4,504
2025-12-19Culley Brian MdirectorA8,925
2025-12-19Culley Brian MdirectorF3341.68$561
2025-12-19Samuel George A. IIIofficerA1,735
2025-12-19Samuel George A. IIIofficerF651.68$109
2025-02-11Samuel George A. IIIofficerM6,076
2025-02-11Samuel George A. IIIofficerF2,4400.65$1,586
2025-02-11Culley Brian MdirectorM31,249
2025-02-11Culley Brian MdirectorF12,5470.65$8,156
2025-01-27BROADWOOD CAPITAL INCten percent ownerP7,894,7370.76$6,000,000
2025-01-27BROADWOOD CAPITAL INCten percent ownerP00$0
2024-11-26Howe Jill AnnofficerP15,0000.59$8,850
2024-11-26Samuel George A. IIIofficerP15,0000.6$9,000
2024-11-22Mulroy Michael H.directorP40,0000.57$22,800
2024-11-21Culley Brian MdirectorP40,0000.6$24,000
2024-08-16Howe Jill AnnofficerP10,5000.89$9,345

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings